A federal bankruptcy judge announced plans to approve Purdue Pharmas restructuring featuring a 74 billion settlement to address claims that the company contributed to the opioid crisis through addictive medications such as OxyContin
Read Full
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
